Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

An adult spindle cell rhabdomyosarcoma in the head and neck region with long-term survival: a case report

  • Stefan Hartmann1Email author,
  • Grit Lessner2,
  • Thomas Mentzel3,
  • Alexander C Kübler1 and
  • Urs DA Müller-Richter1
Journal of Medical Case Reports20148:208

https://doi.org/10.1186/1752-1947-8-208

Received: 22 January 2014

Accepted: 31 March 2014

Published: 19 June 2014

Abstract

Introduction

Spindle cell rhabdomyosarcoma of the head and neck is a very rare tumor in adults. We report on one case with long-term survival.

Case presentation

A 41-year-old nonsmoking Caucasian man presented in June 2007 with a painless swelling under his tongue. A diagnosis of a soft tissue sarcoma, and a myofibrosarcoma in particular, was made via biopsy. After multimodal treatment, including local and systemic therapy, our patient remained disease-free until September 2010. The local recurrence was treated unsuccessfully with various chemotherapy regimens. In September 2011, our patient underwent surgical resection again, and a spindle cell rhabdomyosarcoma was diagnosed. To analyze the mismatch between the original diagnosis of a myofibrosarcoma and the second diagnosis, the two specimens were reassessed, and a final diagnosis of a spindle cell rhabdomyosarcoma was made. In 2012 and 2013, our patient suffered further recurrences that were surgically treated, and he is still alive with disease six years and 10 months after the initial diagnosis in June 2007.

Conclusions

In adults, the spindle cell rhabdomyosarcoma tumor is very rare in the head and neck region. In contrast to childhood tumors, spindle cell rhabdomyosarcoma in adulthood is often associated with a poor prognosis. In the present case, the radical surgical treatment might have helped to prolong the patient’s overall survival, which has lasted more than six years. To our knowledge, this is the longest overall survival reported so far for this tumor entity in the head and neck region.

Keywords

RhabdomyosarcomaSpindle cellAdultSurgeryHead

Introduction

Most malignancies of the oral cavity are squamous cell carcinomas. This tumor entity is strongly related to several risk factors, such as tobacco and alcohol use [1]. Sarcomas of the head and neck region are very rare tumors that are only found in approximately 1% of all head and neck malignancies [2, 3]. In particular, spindle cell rhabdomyosarcoma (sc-rms) was first described in the pediatric population [4]. The occurrence of sc-rms in adults was first reported by Rubin et al., whereas Mentzel et al. described sclerosing pseudovascular rhabdomyosarcoma, an additional morphological variant of sc-rms in adults [5, 6]. In contrast to sc-rms in childhood, sc-rms tumors are very aggressive and associated with a poor prognosis in adults [7]. In further contrast to sc-rms in childhood and adolescence, when the genitourinary tract and the orbital site are most commonly affected, the location of sc-rms in adults is mainly the head and neck region, except for the orbital site [8, 9], and the deep soft tissue of the extremities [10, 11]. Furthermore, Esnaola and colleagues showed that common predictors of survival, such as location, nodal status and histological subtype, are not useful for predicting rhabdomyosarcomas in general. The key factors for predicting overall survival are more likely metastatic disease at presentation, a poor response to chemotherapy, tumor size and a negative margin status after primary resection [8, 10, 12]. The impact of age on survival is still a controversial subject [8, 10, 12]. Although the data available on the prognostic effects of genetic characteristics is still limited, the PAX3-FOXO1 fusion gene and the PAX7-FOXO1 fusion gene, which are associated with alveolar rhabdomyosarcoma, seem to be related with a worse prognosis because of earlier metastatic spread [13, 14]. However, no distinct genetic signature has been reported for sc-rms thus far, although certain cases feature a loss of heterozygosity in chromosome 11p15.5 [15].

Because of the very low incidence of these tumors, clinical knowledge of head and neck rhabdomyosarcoma treatment in adults is very poor, and this treatment leads to unsatisfying results (Table 1).
Table 1

Short overview of the survival rate of similar cases reported in the past

Age (years)

Sex

Follow-up (month)

References

49

F

Died of therapeutic complications (1)

[11]

51

M

Alive without evidence of disease (48)

[7]

38

F

Died of disease (27)

[9]

21

F

Alive without evidence of disease (24)

[9]

38

M

No evidence of disease (1)

[9]

18

M

Alive with disease (17)

[9]

22

M

Alive with disease (16)

[9]

26

F

Alive without evidence of disease (12)

[9]

18

F

Died of disease (20)

[16]

19

M

Died of disease (8)

[16]

33

F

No evidence of disease (1)

[17]

F, female; M, male.

Case presentation

A 41-year-old nonsmoking Caucasian man presented in June 2007 with a painless swelling under his tongue, which was originally thought to be a sialadenitis of the sublingual or submandibular gland. Shortly afterward, a diagnosis of a soft tissue sarcoma, and a myofibrosarcoma in particular, was made via biopsy at another hospital. The following workup revealed no regional or distant spread. The chosen aggressive multimodal treatment was a modified version of a pediatric cooperative soft tissue protocol published in 2002 by the Cooperative Weichteil-Sarkomstudie (CWS) of the Society of Pediatric Oncology. Initially, our patient received three cycles of multiagent chemotherapy (vincristine, dactinomycin and ifosfamide), followed by radiographic restaging. Thereafter, our patient underwent surgical resection, including a radical neck dissection of levels I and IIa on both sides. The original tumor showed a size of 1.3cm in its greatest dimension and blurred edges, with a focal extension into the preepiglottic space margin (R1). Postoperatively, two more cycles of the same multidrug chemotherapy regimen were given in combination with external beam radiation (51 Gray (Gy)) to prevent local treatment failure. Until September 2010, our patient remained disease-free. He then developed local recurrence on the floor of his mouth, without signs of metastatic spread. Our patient was unsuccessfully treated with various chemotherapy regimens (paclitaxel + gemcitabine; Adriamycin® + ifosfamide; Adriamycin® + dimethyl-triazeno-imidazole-carboxamide (DTIC); and Yondelis® (trabectedin)). By August 2011, the tumor had reached a size of 11cm in its greatest dimension, which was the reason for a consult at our department (Oral and Maxillofacial Plastic Surgery) at the University Hospital of Würzburg (Figure 1). After restaging, our patient underwent total glossectomy with modified radical neck dissection on both sides. The epiglottis was removed, but the larynx was preserved. A wide resection of skin in the neck area was also necessary. Reconstruction of the several defects was performed with a latissimus dorsi free flap from the left side (Figure 2). The tumor was diagnosed as an adulthood sc-rms. To analyze the mismatch between the original diagnosis and the second diagnosis, we requested and reevaluated the slides of the original tumor specimen and accordingly corrected the former diagnosis of a myofibrosarcoma to a diagnosis of an adulthood sc-rms. Given negative surgical margins and the previously administered chemotherapies, our patient was discharged after three weeks in a good general condition, without any additional treatment beyond speech therapy. In September 2012, local recurrence in the anterior floor of the mouth was diagnosed and resected. Magnetic resonance imaging of the neck showed several suspicious lymph nodes in the nuchal area. Thereafter, a modified level III re-neck dissection (Robbins) was performed, and the locoregional disease was confirmed by histology. The reoperation was very well tolerated by our patient. This was again followed by a strict follow-up with close intervals. In May 2013, a third local recurrence was confirmed by biopsy. Further resection of the anterior floor of the mouth, parts of the latissimus dorsi flap, the sternocleidomastoid muscle, the right thyroid cartilage and the lateral pharyngeal wall had to be performed. Because of a pathological fracture of the anterior lower jaw that was caused by extensive tumor infiltration, parts of the lower jaw had to be removed as well, and continuity could not be obtained. To date, the patient is still alive with disease and is nourished via a percutaneous endoscopic gastrostomy (PEG) feeding tube.
Figure 1

A preoperative magnetic resonance imaging scan in August 2011. The entire floor of the mouth, including the tongue, is filled by the tumor.

Figure 2

Intraoperative situs after temporary mandibulotomy and tumor resection.

Macroscopically, the resection specimen of the first local recurrence (August, 2011) weighed 724g and contained a well-demarcated tumor measuring 11×8×8cm, without any invasion of the surrounding structures, including the extremely edematous tongue, epiglottis and skin. The cut surface of the tumor was white, firm and fleshy, without hemorrhage or necrosis. Microscopically, the tumor showed variable cellularity and was predominantly composed of spindle-shaped tumor cells with pale eosinophilic, partially ill-defined cytoplasm; an oval, tapered nucleus; vesicular chromatin; and mostly small eosinophilic nucleoli. In certain areas, morphologically, the tumor cells appeared more rounded and epithelioid. The tumor predominantly consisted of highly cellular areas characterized by an arrangement of long and intersecting fascicles of the neoplastic spindle cells, partially resembling a herringbone growth pattern. Occasionally, there were also regions with shorter fascicles of spindle cells surrounded by a collagen matrix. There was no sign of hyaline sclerosis of the intercellular matrix. Admixed throughout the tumor were a variable number of spindle-shaped and tadpole-like rhabdomyoblasts with abundant sparkling eosinophilic cytoplasm, an eccentrically placed nucleus and rare cross-striation. The rhabdomyoblasts were mostly loosely scattered between the spindle cells (Figure 3) and were not very obvious. However, there were also certain areas with lower cellularity and a conspicuous gathering of rhabdomyoblasts. Overall, the rhabdomyoblasts were the most significant morphological clue suggesting the correct diagnosis on conventional light microscopy [7]. Mitoses, including atypical forms, numbered up to 16 per 10 high-power fields (one high-power field = 0.53mm for the microscope used). Focal tumor necrosis was present, accounting for less than 1% of the total tumor volume. There was no obvious lymphangioinvasion or hemangioinvasion and no detectable invasion of the surrounding structures matching the gross description. All surgical resection margins were negative, as were all 52 lymph nodes.Immunohistochemically, the spindle cells partially expressed and the rhabdomyoblasts uniformly expressed desmin (Figures 4 and 5), whereas h-caldesmon staining remained negative. Furthermore, most rhabdomyoblasts and certain spindle cells showed specific nuclear positivity for the myogenic determination factors myogenin and MyoD1 (Figure 4). Actin exhibited focal positivity, with an accentuation at the periphery of the tumor. There was no immunoreactivity of the pan-cytokeratin marker KL1, and no S100, CDK4, MDM 2 or CD117 was detected.
Figure 3

Rhabdomyoblasts are loosely scattered between the spindle cells (hematoxylin and eosin, original magnification x 100).

Figure 4

Distinctive morphology of the spindle cell rhabdomyosarcoma, as indicated by (A) hematoxylin and eosin staining and immunohistochemical staining for (B) desmin and (C) myogenic differentiation 1 (original magnification x 100).

Figure 5

Immunohistochemical staining of desmin (original magnification x 40).

In conclusion, the morphology and the immunophenotype led to the diagnosis of an sc-rms. Furthermore, these features indicated a tumor stage (TNM, 7th edition, 2010) of yrpT2b yrpN0 (0/52) L0 V0 Pn0, a resection status of R0 and a grade G3 tumor with six points in La Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) grading.

Additionally, we directly compared the morphology of the primary tumor specimen and our specimen from the first local recurrence, which showed the same histological features. To finally prove that these two specimens contained the same tumor entity, we complemented the primary immunohistochemical battery with tests for the specific markers of skeletal muscle differentiation myoglobin and MyoD1, which showed the same nuclear expression as described above. Therefore, a diagnosis of a sc-rms was made.

In the following resection specimens (2012 and 2013), including regional lymph nodes, the tumor tissue showed histology identical to that of the tumor described above, corresponding to further local recurrences and regional spread to lymph nodes, respectively.

Discussion

The herein described case of an sc-rms of the head and neck region is very rare. The fact that the specimen was initially misinterpreted as a myofibrosarcoma emphasizes the difficulty in the histopathological diagnosis of these very uncommon entities. In this case, the herringbone growth pattern and the immunoreactivity of desmin and actin represent a diagnostic pitfall, resembling a myofibrosarcoma. However, the admixture of rhabdomyoblasts between the spindle cells and the expression of specific striated muscle markers led to the diagnosis of an sc-rms [15].

Of particular interest in this case is the patient’s overall survival of 82 months since his primary diagnosis in 2007, which is, to our knowledge, the longest overall survival of an adult patient with an sc-rms in the head and neck reported so far. When sc-rms was described for the first time in adults, Rubin et al. hypothesized a very poor outcome with short survival, which was modified by a larger case series by Nascimento and Fletcher in 2005 [6, 9]. Additionally, this case is consistent with the observation that a good response to chemotherapy prolongs overall survival [12] and maximizes the metastasis-free period [8], which is related to a good prognosis. After the primary multimodal therapy, our patient had a disease-free survival period of 38 months, and he is still lacking distant metastases. Moreover, most adult patients affected with sc-rms suffer from a neoplasm of the head and neck region (56.25%) and are male (68.75%). The presented case is consistent with Nascimento’s study concerning sex, location and the possibility of long-term survival [9]. The poorer prognosis of adult sc-rms is in striking contrast to the prognosis of childhood sc-rms, which could be because older patients are less tolerant of intensive chemotherapy and that their tumors are less chemosensitive [8]. Furthermore, in adults, the location in the head and neck region might lead to less aggressive surgical treatment for esthetic reasons and limits the use of wide surgical margins [9]. The radical surgical treatment performed in the presented case could have helped to prolong the patient’s overall survival until today. This treatment might particularly be the reason for the patient’s long survival with disease because most patients rapidly die of the disease after recurrence [8]. Moreover, from a surgical perspective, it is important that tumor-free margins in a histopathological examination cannot predict the absence of local recurrence in the future. In particular, in the case of sarcoma, short follow-up intervals with radiographic control are necessary to detect locoregional recurrence.

Conclusions

In cases of painless swelling in the head and neck region, rare differential diagnoses, such as sarcoma, should particularly be taken into consideration. In addition, an exact histopathological examination is needed because individually adapted therapy regimens are essential to properly treat affected patients. Despite aggressive surgical resection with free margins, local recurrence is common.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Abbreviations

CD117: 

cluster of differentiation 117

CDK4: 

cyclin-dependent kinase 4

DTIC: 

5-(3,3-dimethyl-1-triazenyl) imidazole-4-carboxamide

Gy: 

Gray

KL1: 

katanin-like 1

MDM 2: 

mouse double minute 2 homolog

MyoD1: 

myogenic differentiation 1

PAX3-FOXO1

paired box 3-forkhead box protein O1

PEG: 

percutaneous endoscopic gastrostomy

rms: 

rhabdomyosarcoma

S100: 

S100 calcium-binding protein

sc: 

spindle cell.

Declarations

Acknowledgments

This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding program Open Access Publishing.

Parts of this work were presented as a poster at the annual meeting of the German Society of Oral and Maxillofacial Surgeons (DGMKG) in Bamberg, Germany (31 May 2012 to 2 June 2012).

Authors’ Affiliations

(1)
Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg
(2)
Institute of Pathology, University Würzburg
(3)
Dermatopathologische Gemeinschaftspraxis

References

  1. Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wünsch-Filho V, Franceschi S, Hayes RB, Herrero R, Kelsey K, Koifman S, La Vecchia C, Lazarus P, Levi F, Lence JJ, Mates D, Matos E, Menezes A, McClean MD, Muscat J, Eluf-Neto J, Olshan AF, Purdue M, Rudnai P: Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009, 18: 541550-View ArticleGoogle Scholar
  2. Brockstein B: Management of sarcomas of the head and neck. Curr Oncol Rep. 2004, 6: 321-327.View ArticlePubMedGoogle Scholar
  3. Turner JH, Richmon JD: Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data. Otolaryngol Head Neck Surg. 2011, 145: 967-973.View ArticlePubMedGoogle Scholar
  4. Cavazzana AO, Schmidt D, Ninfo V, Harms D, Tollot M, Carli M, Treuner J, Betto R, Salviati G: Spindle cell rhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol. 1992, 16: 229-235.View ArticlePubMedGoogle Scholar
  5. Mentzel T, Katenkamp D: Sclerosing, pseudovascular rhabdomyosarcoma in adults. Clinicopathological and immunohistochemical analysis of three cases. Virchows Arch. 2000, 436: 305-311.View ArticlePubMedGoogle Scholar
  6. Rubin BP, Hasserjian RP, Singer S, Janecka I, Fletcher JA, Fletcher CD: Spindle cell rhabdomyosarcoma (so-called) in adults: report of two cases with emphasis on differential diagnosis. Am J Surg Pathol. 1998, 22: 459-464.View ArticlePubMedGoogle Scholar
  7. Mentzel T, Kuhnen C: Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases. Virchows Arch. 2006, 449: 554-560.View ArticlePubMedGoogle Scholar
  8. Little DJ, Ballo MT, Zagars GK, Pisters PW, Patel SR, El-Naggar AK, Garden AS, Benjamin RS: Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer. 2002, 95: 377-388.View ArticlePubMedGoogle Scholar
  9. Nascimento AF, Fletcher CD: Spindle cell rhabdomyosarcoma in adults. Am J Surg Pathol. 2005, 29: 1106-1113.PubMedGoogle Scholar
  10. Hawkins WG, Hoos A, Antonescu CR, Urist MJ, Leung DH, Gold JS, Woodruff JM, Lewis JJ, Brennan MF: Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer. 2001, 91: 794-803.View ArticlePubMedGoogle Scholar
  11. Stock N, Chibon F, Binh MB, Terrier P, Michels JJ, Valo I, Robin YM, Guillou L, Ranchere-Vince D, Decouvelaere AV, Collin F, Birtwisle-Peyrottes I, Gregoire F, Aurias A, Coindre JM: Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis. Am J Surg Pathol. 2009, 33: 1850-1859.View ArticlePubMedGoogle Scholar
  12. Esnaola NF, Rubin BP, Baldini EH, Vasudevan N, Demetri GD, Fletcher CD, Singer S: Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma. Ann Surg. 2001, 234: 215-223.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Belyea B, Kephart JG, Blum J, Kirsch DG, Linardic CM: Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targeting. Sarcoma. 2012, 2012: 406239-View ArticlePubMedPubMed CentralGoogle Scholar
  14. Linardic CM: PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett. 2008, 270: 10-18.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Mentzel T: [Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues]. Pathologe. 2010, 31: 91-96.View ArticlePubMedGoogle Scholar
  16. Franca CM, Caran EM, Alves MT, Barreto AD, Lopes NN: Rhabdomyosarcoma of the oral tissues–two new cases and literature review. Med Oral Patol Oral Cir Bucal. 2006, 11: E136-E140.PubMedGoogle Scholar
  17. Chi AC, Barnes JD, Budnick S, Agresta SV, Neville B: Rhabdomyosarcoma of the maxillary gingiva. J Periodontol. 2007, 78: 1839-1845.View ArticlePubMedGoogle Scholar

Copyright

© Hartmann et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement